{
    "clinical_study": {
        "@rank": "8304", 
        "acronym": "CRIO-DBS", 
        "arm_group": [
            {
                "arm_group_label": "Long Pulse Width", 
                "arm_group_type": "Experimental", 
                "description": "deep brain stimulation with short & long pulse width"
            }, 
            {
                "arm_group_label": "Short Pulse Width", 
                "arm_group_type": "Experimental", 
                "description": "deep brain stimulation with short & long pulse width"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to examine the effects of sub-callosal cingulate (SCC) deep\n      brain stimulation (DBS) in patients with treatment resistant depression (TRD).\n\n      The working hypotheses are that long pulse-width DBS applied to the SCC region will lead to\n      improvements in TRD patients, and specific neuroimaging biomarkers will correlate with\n      response to DBS; the functional recovery will be enhanced with concurrent cognitive\n      behavioural therapy (CBT)."
        }, 
        "brief_title": "DBS for Treatment Resistant Depression", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Depressive Disorder, Treatment-Resistant", 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder"
            ]
        }, 
        "detailed_description": {
            "textblock": "The aim is to collect data on prediction, optimization and augmentation of DBS for TRD and\n      develop tools for DBS surgery. It is a biological pilot study designed to provide\n      informative data for future work."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age 20-60\n\n          -  diagnosis of major depressive (MDD)or bipolar disorder(BP)determined independently by\n             2 study psychiatrists\n\n          -  current major depressive episode of >1 year duration, treatment-resistant (meaning\n             failure to respond to 4 different classes of antidepressants, including augmentation\n             or combination strategies with lithium, atypical antipsychotics, anticonvulsants,\n             antidepressants, evidence-based psychotherapy, CBT, or electroconvulsive treatment\n             despite adequate dosage, duration and compliance)\n\n          -  minimum score of 20 (out of 52) on the 17 item Hamilton Depression Rating Scale\n             (HDRS)\n\n        Exclusion Criteria:\n\n          -  other Axis I psychiatric disorders including schizophrenia, psychosis, active\n             suicidal ideation over previous 6 months\n\n          -  cerebrovascular risk factors, previous stroke, head injury and neurodegenerative\n             disorders, pregnancy, medical and general contraindications for DBS surgery (e.g.\n             cardiac pacemaker/defibrillator)\n\n          -  age >60\n\n          -  diabetes"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01983904", 
            "org_study_id": "E-20948"
        }, 
        "intervention": {
            "arm_group_label": [
                "Long Pulse Width", 
                "Short Pulse Width"
            ], 
            "description": "surgical implantation for bilateral electrodes and stimulation using short and long pulse width", 
            "intervention_name": "deep brain stimulation with short & long pulse width", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Major depressive disorder (MDD)", 
            "Bi-polar disorder (BP)"
        ], 
        "lastchanged_date": "May 20, 2014", 
        "location": {
            "contact": {
                "email": "sgolding@ucalgary.ca", 
                "last_name": "Sandra Golding, MscHA BN RN", 
                "phone": "4032106905"
            }, 
            "contact_backup": {
                "email": "rramasub@ucalgary.ca", 
                "last_name": "Rajamannar Ramasubbu, MD,MRCPsych,FRCP(C),MSc", 
                "phone": "4032106890"
            }, 
            "facility": {
                "address": {
                    "city": "Calgary", 
                    "country": "Canada", 
                    "state": "Alberta", 
                    "zip": "T2N 4Z6"
                }, 
                "name": "University of Calgary & Alberta Health Services, Foothills Medical Centre"
            }, 
            "investigator": [
                {
                    "last_name": "Zelma H Kiss, MD PhD FRCSC", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Rajamannar Ramasubbu, MD,MRCPsych,FRCP(C),MSc", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Therapeutic Brain Stimulation for Refractory Depression", 
        "overall_contact": {
            "email": "sgolding@ucalgary.ca", 
            "last_name": "Sandra Golding, MScHA BN RN", 
            "phone": "4032106905"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Calgary, Department of Clinical Neurosciences", 
                "last_name": "Zelma H Kiss, MD PhDFRCSC", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Calgary, Department of Psychiatry", 
                "last_name": "Rajamannar Ramasubbu, MD MRCP FRC MSc", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: There is no oversight authority", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "change in HDRS from baseline before surgery: rates of remission (defined as an HDRS score <8 at 6 and 12 months) and response (defined as >50% reduction in HDRS)", 
            "measure": "Change in Hamilton Depression Rating Scale", 
            "safety_issue": "No", 
            "time_frame": "6 and 12 months post-operatively"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01983904"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Calgary", 
            "investigator_full_name": "Zelma Kiss", 
            "investigator_title": "Associate Professor, Neurosurgery; Director Clinician Investigator Program", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline on Illness Density Index, Montgomery-Asberg Depression Rating Scale and Hamilton Anxiety Scale, Positive and Negative Affect Scale, Clinical Global Impression of Change, GAF< SAs, NAS, Q-LES-Q-SF & neuropsychological tests", 
                "safety_issue": "No", 
                "time_frame": "6 and 12 months post operatively"
            }, 
            {
                "description": "Changes in primary and secondary measures from pre-CBT scores will be used", 
                "measure": "Post Cognitive Behavioural Therapy Scores", 
                "safety_issue": "No", 
                "time_frame": "15 months post operatively"
            }
        ], 
        "source": "University of Calgary", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Calgary", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}